ERIS Lifesciences Shareholding

ERIS Lifesciences Ltd Shareholding Pattern

The ERIS Lifesciences Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the ERIS Lifesciences Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

ERIS Lifesciences Ltd (NSE: ERIS, BSE: 540596) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the ERIS Lifesciences Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

ERIS Lifesciences Ltd Shareholding Pattern (Latest)

The latest ERIS Lifesciences Ltd shareholding for Mar 2026 is:

• Promoters: 53.92%
• FII: 6.39%
• DII: 20.35%
• Public: 19.33%
• Government: 0%

A slight decline in promoter holding may indicate stake dilution or strategic selling.

ERIS Lifesciences Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in ERIS Lifesciences Ltd.

• Mar 2026: 53.92%
• Dec 2025: 54.85%
• Sept 2025: 54.85%
• Jun 2025: 54.84%
• Mar 2025: 54.85%

Promoter stake remains largely stable, showing consistent ownership structure.

ERIS Lifesciences Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward ERIS Lifesciences Ltd.

• Mar 2026: 6.39%
• Dec 2025: 6.85%
• Sept 2025: 7.21%
• Jun 2025: 8.40%
• Mar 2025: 8.43%

FII holding has declined, suggesting cautious sentiment among foreign investors.

ERIS Lifesciences Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Mar 2026: 20.35%
• Dec 2025: 20.32%
• Sept 2025: 19.36%
• Jun 2025: 18.17%
• Mar 2025: 18.07%

DII stake in ERIS Lifesciences Ltd has increased over time, indicating growing domestic institutional confidence.

ERIS Lifesciences Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Mar 2026: 19.33%
• Dec 2025: 17.99%
• Sept 2025: 18.57%
• Jun 2025: 18.59%
• Mar 2025: 18.66%

Public participation in ERIS Lifesciences Ltd has increased, indicating rising retail investor interest.

ERIS Lifesciences Ltd Government Holding

Government holding in ERIS Lifesciences Ltd currently stands at 0%.

ERIS Lifesciences Ltd operates without significant government ownership.

ERIS Lifesciences Ltd Shareholding Analysis Summary

The ERIS Lifesciences Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

ERIS Lifesciences Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.

Regular monitoring of the ERIS Lifesciences Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.